Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes

Journal of Hepatology

Volumn 59, Issue 4, 2013, Pages 701-708

  Brownell, Jessica ^a   Wagoner, Jessica ^a   Lovelace, Erica S ^a   Thirstrup, Derek ^a   Mohar, Isaac ^b   Smith, Wesley ^a   Giugliano, Silvia ^c   Li, Kui ^d   Crispe, I Nicholas ^b   Rosen, Hugo R ^c   Polyak, Stephen J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Seattle BioMed   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

HCV; Non parenchymal cells; RIG I; TLR3; Type I interferon; Type III interferon

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3;

ARTICLE; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; LIVER CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; VIRUS CARCINOGENESIS;

ACTIVATOR PROTEIN-1; AP-1; HCV; HEPATITIS C VIRUS; IFIT1; IFN; IFN-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 1; INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON STIMULATED GENE; INTERFERON STIMULATED RESPONSE ELEMENT; IRF; ISG; ISRE; KCS; KUPFFER CELLS; LIVER SINUSOIDAL ENDOTHELIAL CELLS; LSECS; MAVS; MITOCHONDRIAL ANTIVIRAL-SIGNALING PROTEIN; MOI; MULTIPLICITY OF INFECTION; NATURAL KILLER; NF-ΚB; NK; NON-PARENCHYMAL CELLS; NPCS; NUCLEAR FACTOR-ΚB; PAMP; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; PHH; PRIMARY HUMAN HEPATOCYTES; PRR; RETINOIC ACID INDUCIBLE GENE I; RIG-I; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; STAT; TIR-DOMAIN-CONTAINING ADAPTER-INDUCING IFN-Β; TLR3; TNF-Α; TOLL-LIKE RECEPTOR 3; TRIF; TUMOR NECROSIS FACTOR Α; TYPE I INTERFERON; TYPE III INTERFERON;

CELL LINE; CHEMOKINE CXCL10; DEAD-BOX RNA HELICASES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; INTERFERONS; NEUTRALIZATION TESTS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 3;

EID: 84884414087     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.06.001     Document Type: Article

References (48)

1. K.J. Helbig, A. Ruszkiewicz, R.E. Lanford, M.D. Berzsenyi, H.A. Harley, and S.R. McColl Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro J Virol 83 2009 836 846
2. J.-R. Larrubia, M. Calvino, S. Benito, E. Sanz-de-Villalobos, C. Perna, and J. Pérez-Hornedo The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection J Hepatol 47 2007 632 641 (Pubitemid 47503421)
3. J. Wang, T.H. Holmes, R. Cheung, H.B. Greenberg, and X.-S. He Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation J Infect Dis 190 2004 989 997 (Pubitemid 39120979)
4. A.E. Carpenter, T.R. Jones, M.R. Lamprecht, C. Clarke, I.H. Kang, and O. Friman Cell Profiler: image analysis software for identifying and quantifying cell phenotypes Genome Biol 7 2006 R100
5. T. Aoyama, Y.-H. Paik, and E. Seki Toll-like receptor signaling and liver fibrosis Gastroenterol Res Pract 2010 2010
6. J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, and D.R. Burton Robust hepatitis C virus infection in vitro Proc Natl Acad Sci U S A 102 2005 9294 9299 (Pubitemid 40923557)
7. M. Zeremski, L.M. Petrovic, L. Chiriboga, Q.B. Brown, H.T. Yee, and M. Kinkhabwala Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C Hepatology (Baltimore, Md.) 48 2008 1440 1450
8. J.M. Darling, J. Aerssens, G. Fanning, J.G. McHutchison, D.B. Goldstein, and A.J. Thompson Quantitation of pretreatment serum interferon-γ- inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response Hepatology (Baltimore, Md.) 53 2011 14 22
9. G. Askarieh, A. Alsiö, P. Pugnale, F. Negro, C. Ferrari, and A.U. Neumann Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C Hepatology (Baltimore, Md.) 51 2010 1523 1530
10. M. Zeremski, G. Hooker, M.A. Shu, E. Winkelstein, Q. Brown, and D.C. Jarlais Des Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection J Hepatol 55 2011 545 553
11. R. Sumpter, Y.-M. Loo, E. Foy, K. Li, M. Yoneyama, and T. Fujita Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I J Virol 79 2005 2689 2699 (Pubitemid 40270547)
12. K. Li, Z. Chen, N. Kato, M. Gale, and S.M. Lemon Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes J Biol Chem 280 2005 16739 16747 (Pubitemid 41389131)
13. N. Wang, Y. Liang, S. Devaraj, J. Wang, S.M. Lemon, and K. Li Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells J Virol 83 2009 9824 9834
14. K. Li, N.L. Li, D. Wei, S.R. Pfeffer, M. Fan, and L.M. Pfeffer Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates Hepatology (Baltimore, Md.) 55 2012 666 675
15. T. Saito, D.M. Owen, F. Jiang, J. Marcotrigiano, and M. Gale Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA Nature 454 2008 523 527
16. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738 (Pubitemid 33009951)
17. M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi, and K. Takeda Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling J Immunol 169 2002 6668 6672 (Pubitemid 36899248)
18. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
19. P.I. Osterlund, T.E. Pietilä, V. Veckman, S.V. Kotenko, and I. Julkunen IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes J Immunol 179 2007 3434 3442
20. N. Ank, H. West, and S.R. Paludan IFN-lambda: novel antiviral cytokines J Interferon Cytokine Res 26 2006 373 379
21. D.S. Aaronson, and C.M. Horvath A road map for those who don't know JAK-STAT Science 296 2002 1653 1655 (Pubitemid 34579157)
22. E. Thomas, V.D. Gonzalez, Q. Li, A.A. Modi, W. Chen, and M. Noureddin HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons Gastroenterology 142 2012 978 988
23. S. Marukian, L. Andrus, T.P. Sheahan, C.T. Jones, E.D. Charles, and A. Ploss Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures Hepatology (Baltimore, Md.) 54 2011 1913 1923
24. J.C.L. Spurrell, S. Wiehler, R.S. Zaheer, S.P. Sanders, and D. Proud Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection Am J Physiol Lung Cell Mol Physiol 289 2005 L85 L95
25. C.E. Harvey, J.J. Post, P. Palladinetti, A.J. Freeman, R.A. Ffrench, and R.K. Kumar Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation J Leukoc Biol 74 2003 360 369 (Pubitemid 38040396)
26. M. Maire, R. Parent, A.-L. Morand, C. Alotte, C. Trépo, and D. Durantel Characterization of the double-stranded RNA responses in human liver progenitor cells Biochem Biophys Res Commun 368 2008 556 562
27. Biosystems A. Guide to performing relative quantitation of gene expression using real-time quantitative PCR; 2008: 1-70. Available from: http://www3.appliedbiosystems.com/cms/groups/mcb-support/documents/ generaldocuments/cms-042380.pdf.
28. A. Alcamí, J.A. Symons, and G.L. Smith The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN J Virol 74 2000 11230 11239 (Pubitemid 32223991)
29. S. Preiss, A. Thompson, X. Chen, S. Rodgers, V. Markovska, and P. Desmond Characterization of the innate immune signalling pathways in hepatocyte cell lines J Viral Hepat 15 2008 888 900
30. R. Broering, J. Wu, Z. Meng, P. Hilgard, M. Lu, and M. Trippler Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication J Hepatol 48 2008 914 922
31. I.S. Trowbridge, and M.L. Thomas CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development Annu Rev Immunol 12 1994 85 116 (Pubitemid 24140410)
32. C.L. Holness, and D.L. Simmons Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins Blood 81 1993 1607 1613 (Pubitemid 23083842)
33. M. Kinoshita, T. Uchida, A. Sato, M. Nakashima, H. Nakashima, and S. Shono Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice J Hepatol 53 2010 903 910
34. R.C. Huebert, K. Jagavelu, A.F. Liebl, B.Q. Huang, P.L. Splinter, and N.F. LaRusso Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis Lab Invest 90 2010 1770 1781
35. M.H. Heim Innate immunity and HCV J Hepatol 58 2013 564 574
36. M. Sarasin-Filipowicz, E.J. Oakeley, F.H.T. Duong, V. Christen, L. Terracciano, and W. Filipowicz Interferon signaling and treatment outcome in chronic hepatitis C Proc Natl Acad Sci U S A 105 2008 7034 7039 (Pubitemid 351754525)
37. H. Park, E. Serti, O. Eke, B. Muchmore, L. Prokunina-Olsson, and S. Capone IL29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection Hepatology (Baltimore, Md.) 56 2012 2060 2070
38. V. Veckman, P. Osterlund, R. Fagerlund, K. Melén, S. Matikainen, and I. Julkunen TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells Virology 345 2006 96 104 (Pubitemid 43107575)
39. S.E. Collins, R.S. Noyce, and K.L. Mossman Innate cellular response to virus particle entry requires IRF3 but not virus replication J Virol 78 2004 1706 1717 (Pubitemid 38176703)
40. V.R. DeFilippis, B. Robinson, T.M. Keck, S.G. Hansen, J.A. Nelson, and K.J. Früh Interferon regulatory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infection J Virol 80 2006 1032 1037 (Pubitemid 43062914)
41. C. Wu, Y. Ohmori, S. Bandyopadhyay, G. Sen, and T. Hamilton Interferon-stimulated response element and NF kappa B sites cooperate to regulate double-stranded RNA-induced transcription of the IP-10 gene J Interferon Res 14 1994 357 363
42. J. Wagoner, M. Austin, J. Green, T. Imaizumi, A. Casola, and A. Brasier Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection J Virol 81 2007 309 318 (Pubitemid 44975171)
43. T. Kawai, and S. Akira Toll-like Receptor and RIG-1-like Receptor Signaling Ann N Y Acad Sci 1143 2008 1 20
44. Y.-C. Lu, I. Kim, E. Lye, F. Shen, N. Suzuki, and S. Suzuki Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines J Immunol 182 2009 7212 7221
45. G.M. Reynolds, H.J. Harris, A. Jennings, K. Hu, J. Grove, and P.F. Lalor Hepatitis C virus receptor expression in normal and diseased liver tissue Hepatology (Baltimore, Md.) 47 2008 418 427 (Pubitemid 351280709)
46. M.T. Dill, Z. Makowska, F.H.T. Duong, F. Merkofer, M. Filipowicz, and T.F. Baumert Interferon-γ-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C Gastroenterology 143 2012 777 786 e1-6
47. K. Schroder, P.J. Hertzog, T. Ravasi, and D.A. Hume Interferon-gamma: an overview of signals, mechanisms and functions J Leukoc Biol 75 2004 163 189 (Pubitemid 38174573)
48. A. Casrouge, J. Decalf, M. Ahloulay, C. Lababidi, H. Mansour, and A. Vallet-Pichard Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV J Clin Invest 121 2011 308 317